Viewing Study NCT03963206


Ignite Creation Date: 2025-12-26 @ 2:40 PM
Ignite Modification Date: 2025-12-30 @ 1:49 PM
Study NCT ID: NCT03963206
Status: COMPLETED
Last Update Posted: 2025-12-01
First Post: 2019-05-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module